Toyobo Co (3101) Q3 2025 earnings summary

Executive summary

• Net sales rose 2.2% year-over-year to ¥314.2 billion, with operating profit up 103.8% to ¥10.2 billion, driven by strong Industrial film and Environmental and Functional Materials segments, and improved profitability in underperforming businesses.

• Net profit attributable to owners fell 54.2% year-over-year to ¥0.7 billion, mainly due to extraordinary losses, higher non-operating expenses, and increased profit attributable to non-controlling interests.

• Comprehensive income increased 72.8% year-over-year to ¥5.7 billion.

• Ordinary profit rose 131.0% year-over-year to ¥5.5 billion.

• Extraordinary losses and higher non-operating expenses impacted net profit despite operational gains.

Financial highlights

• Net sales: ¥314.2 billion (+2.2% YoY); Operating profit: ¥10.2 billion (+103.8% YoY); Net profit: ¥0.7 billion (-54.2% YoY); Ordinary profit: ¥5.5 billion (+131.0% YoY).

• EBITDA increased 39.5% YoY to ¥27.1 billion.

• Gross profit margin improved to 22.6% from 21.1% YoY; gross profit rose to ¥71.1 billion from ¥64.8 billion.

• EPS dropped to ¥8.2 from ¥17.9 YoY.

• Total assets grew 1.2% to ¥614.1 billion; net assets rose 1.0% to ¥232.5 billion.

Outlook and guidance

• FY 3/25 forecast: Net sales ¥435.0 billion (+5.0%), operating profit ¥17.0 billion (+89.0%), ordinary profit ¥11.5 billion (+65.2%), net profit ¥2.6 billion (+5.9%), EPS ¥29.50.

• Industrial film expected to remain strong; Life Science segment to see profit decrease.

• CAPEX planned at ¥45.0 billion, focused on new equipment and plant upgrades.

• No changes to previously announced earnings or dividend forecasts.